ELUDE
Dead / Abandoned — Abandoned — no statement of use filed (as of 11 Aug 2025)
What this means for you
This application is over — abandoned 11 Aug 2025. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 97471499
- Mark type
- Stylized text
- Filed
- 22 Jun 2022
- Published for opposition
- 09 May 2023
- Abandoned
- 11 Aug 2025
- Attorney of record
- John V. Hobgood, Esquire
Goods and services
- Class 005 — Pharmaceuticals: Gene therapy products, namely, engineered cell platforms for immunotherapy purposes; Pharmaceutical preparations for use in the treatment of autoimmune diseases and disorders, autoinflammatory diseases and disorders, alloimmune diseases and disorders and allergic diseases and disorders
- Class 040 — Treatment of materials: Custom manufacture of pharmaceuticals for others; Custom manufacturing of biological cells; consultation in the field of custom manufacture of pharmaceuticals and biological cells
- Class 042 — Scientific and technological services: Scientific research; Pharmaceutical research; Medical research; Engineering of biological cells; genetic engineering of biological cells; Technological consultation services in the fields of engineering of biological cells; Laboratory research services in the field of immunology and cellular engineering
Owner
- GentiBio, Inc., Cambridge, MA, US
- GentiBio, Inc., Cambridge, MA, US
Prosecution history
- 11 Aug 2025 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 11 Aug 2025 — ABANDONMENT - NO USE STATEMENT FILED
- 03 Mar 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 21 Dec 2024 — SOU EXTENSION 3 GRANTED
- 20 Dec 2024 — SOU EXTENSION 3 FILED
- 20 Dec 2024 — SOU TEAS EXTENSION RECEIVED
- 03 Jul 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 03 Jul 2024 — SOU EXTENSION 2 GRANTED
- 03 Jul 2024 — SOU EXTENSION 2 FILED
- 02 Jul 2024 — SOU TEAS EXTENSION RECEIVED
- 06 Jan 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 04 Jan 2024 — SOU EXTENSION 1 GRANTED
- 04 Jan 2024 — SOU EXTENSION 1 FILED
- 04 Jan 2024 — SOU TEAS EXTENSION RECEIVED
- 04 Jul 2023 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT